Italy. Covid-19 infection reaches 59.138 with 5.476 deaths. Slowing trends of new cases and deaths recorded today for the first time.
A slowdown of the rising trends in the number of Covid infections and deaths was recorded today by the Italian Civil Protection. Healthcare workers infected rise to 4,824 and now their testing is prioritized. The total lockdown in Italy is confirmed until April 3rd.
For every region, find the number if patients still positive:
- 17.885 patients in Lombardia
- 6.390 in Emilia Romagna
- 4.644 in Veneto
- 4.127 in Piedmont
- 2.231 in Marche
- 2.144 in Tuscany
- 1.351 in Liguria
- 1.272 in Lazio
- 866 in Campania
- 738 in Friuli Venezia Giulia
- 885 in the Pa of Trento
- 648 in the province of Bolzano
- 748 in Puglia
- 596 in Sicily
- 539 in Abruzzo
- 500 in Umbria
- 354 in Aosta Valley
- 327 in Sardinia (+6)
- 260 in Calabria (+35)
- 81 in Basilicata
- 52 in Molise
Download today’s report from Italian Health Authorities.
For real-time updated numbers:
- https://statistichecoronavirus.it/aggiornamento-contagiati-italia/
- https://github.com/pcm-dpc/COVID-19
Requirements for prioritization of testing of healthcare workers have been published.
Contact Meditrial to discover rapid workflows to rescue your research.
Table of Contents
Build a Defensible Clinical Evidence Strategy Under EU MDR
Build a defensible clinical evidence strategy under MDR Annex XIV, from the clinical evaluation plan to PMCF and notified body review.
Getting a CE mark for medical devices: a step-by-step guide
Practical guidance on the CE mark for medical devices under EU MDR, from classification and evidence to conformity assessment and EUDAMED
A Practical RBQM Framework for Medical Device Trials
Risk-based quality management for medical device trials, with practical actions for risk assessment, monitoring, data review, and trial oversight
EU Breakthrough Medical Devices Under MDCG 2025-9 (BtX)
EU breakthrough medical devices gain a clearer regulatory pathway under MDCG 2025-9, with early advice and lifecycle evidence planning
What Swissmedic Fast-Track Means for Clinical Trial Sponsors
Swissmedic swissethics Fast-Track Pilot Project accelerates eligible trial reviews and makes coordinated regulatory preparation increasingly important.
FDA Breakthrough Device Acceleration
How innovative MedTech companies can accelerate FDA approval, secure Medicare coverage, and reach patients faster—starting with Breakthrough Device Designation.
This article provides general information and does not constitute regulatory or legal advice. Requirements should be confirmed for the specific study, applicable regulatory framework, and markets concerned.
